{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:03:21Z","timestamp":1768637001446,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.062","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T09:24:00Z","timestamp":1286184240000},"page":"7748-7756","source":"Crossref","is-referenced-by-count":27,"title":["Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)"],"prefix":"10.1016","volume":"28","author":[{"given":"Patricia","family":"Fellows","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Adamovicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Hartings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Mega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Brasel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lou","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Rom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Blackwelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Snow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Kate","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.062_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis \u2013 etiological agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"RR-14","key":"10.1016\/j.vaccine.2010.09.062_bib0010","first-page":"1","article-title":"Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"Gage","year":"1996","journal-title":"MMWR"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.062_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pmed.0050003","article-title":"Plague: past, present, and future","volume":"5","author":"Stenseth","year":"2008","journal-title":"PLoS Med"},{"issue":"17","key":"10.1016\/j.vaccine.2010.09.062_bib0020","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon, medical and public health management","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0025","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/infdis\/129.Supplement_1.S37","article-title":"Plague immunization: V. Indirect evidence for the efficacy of plague vaccine","volume":"129","author":"Cavanaugh","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microb"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.062_bib0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"11\/112","key":"10.1016\/j.vaccine.2010.09.062_bib0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0050","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0055","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull World Health Organ"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2010.09.062_bib0060","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization: I. Past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2010.09.062_bib0065","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/129.Supplement_1.S19","article-title":"Plague immunization. II. Relation of adverse clinical reactions to multiple immunization with killed vaccine","volume":"129","author":"Marshal","year":"1974","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.062_bib0070","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.062_bib0075","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.vaccine.2010.02.022","article-title":"A parenteral DNA vaccine protects against pneumonic plague","volume":"28","author":"Yamanaka","year":"2010","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2010.09.062_bib0080","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.vaccine.2010.06.054","article-title":"Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice","volume":"28","author":"Brewoo","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.062_bib0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/hum.2009.148","article-title":"Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsid antigen incorporated into adenovirus capsid","volume":"21","author":"Boyer","year":"2010","journal-title":"Hum Gene Ther"},{"issue":"36","key":"10.1016\/j.vaccine.2010.09.062_bib0090","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1016\/j.vaccine.2010.06.020","article-title":"Protection against pneumonic plague following oral administration with a non-replicating vaccine","volume":"28","author":"Jones","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(99)00197-2","article-title":"Generation of protective immune response to plague by muscosal administration of microsphere coencapsulated recombinant subunits","volume":"63","author":"Eyles","year":"2000","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.062_bib0100","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0105","unstructured":"Pitt ML. Non-human primates as a model for pneumonic plague. In: Animal models and correlates of protection for plague vaccines workshop. Gaithersburg, MD; October 13\u201314, 2004. http:\/\/www.fda.gov\/cber\/minutes\/plague101304t.pdf."},{"issue":"16","key":"10.1016\/j.vaccine.2010.09.062_bib0110","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.vaccine.2007.01.071","article-title":"Development of a recombinant vaccine against aerosolized plague","volume":"25","author":"Morris","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.062_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0125","first-page":"1","article-title":"Studies on plague immunity in experimental animals","author":"Jawetz","year":"1943","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0130","first-page":"75","article-title":"Measurement of protective serum antibodies in human volunteers inoculated with plague prophylactics","volume":"6","author":"Meyer","year":"1948","journal-title":"Stanford Med Bull"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.062_bib0135","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/IAI.62.10.4192-4201.1994","article-title":"Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.062_bib0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige mouse as a model to investigate protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"FEMS Immunol Med Microb"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0150","unstructured":"Andrews GP, Bolt CR, Pitt LM, Adamovicz JJ. Passive protection in mice from fatal pneumonic plague by antibody raised against a recombinant Yersinia pestis F1-V fusion protein vaccine candidate. American Society for Microbiology Biodefense Research Meeting; March 7\u201310, 2004."},{"issue":"42","key":"10.1016\/j.vaccine.2010.09.062_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of the potential immune correlates","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0160","doi-asserted-by":"crossref","unstructured":"Fellows PF, Adamovicz JJ, Norris S, Blackwelder B, Morris S. Protection in mice passively immunized with serum from cynomolgus macaques vaccinated with recombinant plague vaccine (rF1V). American Society for Microbiology Biodefense and Emerging Disease Research Meeting; February 22\u201325, 2009.","DOI":"10.1016\/j.vaccine.2010.09.062"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0165","series-title":"Institute of Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals","article-title":"National Research Council","year":"1996"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.06.002","article-title":"Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products","volume":"289","author":"Mire-Sluis","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jpba.2005.04.045","article-title":"Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies","volume":"39","author":"Geng","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am J Physiol"},{"key":"10.1016\/j.vaccine.2010.09.062_bib0185","unstructured":"Center for Drug Evaluation and Research. Guidance for industry: animal models \u2013 essential elements to address efficacy under the animal rule. Food and Drug Administration Department of Health and Human Services, Rockville, MD; 2009 http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM078923.pdf."},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.062_bib0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with Yersinia pestis","volume":"14","author":"Bashaw","year":"2007","journal-title":"Clin Vac Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2010.09.062_bib0195","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2008.01.033","article-title":"Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague","volume":"26","author":"Zauberman","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.062_bib0200","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/CVI.00091-08","article-title":"Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection","volume":"15","author":"Welkos","year":"2008","journal-title":"Clin Vac Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T10:07:10Z","timestamp":1591956430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10013836"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}